In continuation of earlier announcements dated February 14, 2023 and February 17, 2023, Orchid Pharma has informed that the Transcript of Investors Call/Earning Call held on Friday, February 17, 2023 on the Un-Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine Months ended December 31, 2022 is enclosed. Further, pursuant to Regulation 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the aforesaid transcript is available on the Company's website: www.orchidpharma.com.
The above information is a part of company’s filings submitted to BSE.
